ALDH2 may counteract reactive oxygen species (ROS)-induced lipid aldehyde formation, which has been described in obesity and insulin resistance (Pillon and Soulage, 2012). Here, ALDH2 is linked to obesity due to melanocortin 4 receptor deficiency.